Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer’s Disease
Year: 2023
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The complex and not yet fully understood etiology of Alzheimer's disease (AD) shows important proteopathic signs which are unlikely to be linked to a single protein. However, protein subsets from deep proteomic datasets can be useful in stratifying patient risk, identifying stage dependent disease markers, and suggesting possible disease mechanisms. OBJECTIVE: The objective was to identify protein subsets that best classify subjects into control, asymptomatic Alzheimer's disease (AsymAD), and AD. METHODS: Data comprised 6 cohorts; 620 subjects; 3,334 proteins. Brain tissue-derived predictive protein subsets for classifying AD, AsymAD, or control were identified and validated with label-free quantification and machine learning. RESULTS: A 29-protein subset accurately classified AD (AUC = 0.94). However, an 88-protein subset best predicted AsymAD (AUC = 0.92) or Control (AUC = 0.92) from AD (AUC = 0.98). AD versus Control: APP, DHX15, NRXN1, PBXIP1, RABEP1, STOM, and VGF. AD versus AsymAD: ALDH1A1, BDH2, C4A, FABP7, GABBR2, GNAI3, PBXIP1, and PRKAR1B. AsymAD versus Control: APP, C4A, DMXL1, EXOC2, PITPNB, RABEP1, and VGF. Additional predictors: DNAJA3, PTBP2, SLC30A9, VAT1L, CROCC, PNP, SNCB, ENPP6, HAPLN2, PSMD4, and CMAS. CONCLUSION: Biomarkers were dynamically separable across disease stages. Predictive proteins were significantly enriched to sugar metabolism.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-220683
Institutions: Georgia Institute of Technology, Emory University
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Awards: CAREER: A systems engineering approach to elucidate and treat multi-factorial pathology, G2409549499, G3026342146, G3486421421, G3962885547, G3968148973, G4183424045, G49689694, G4998539894, G556672640, G6671297155, Emory Alzheimer's Disease Center, Precision Aging Network: Closing the Gap Between Cognitive Healthspan andHuman Lifespan, Goizueta Alzheimer's Disease Research Center
OpenAlex ID: W4319345240
